Recurrent Squamous Cell Carcinoma of the Larynx Terminated Phase 1 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0028811 (Recurrent Squamous Cell Carcinoma of the Larynx)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01249443Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionTreatment